<h3>涨幅榜</h3>
<ul>
<li><strong>Greenwich LifeSciences</strong> (NASDAQ: GLSI) 股票在周一的常规交易中上涨了 25.5%，至 $25.96。该公司的市值为 2.765 亿美元。</li>
<li><strong>Nutriband</strong> (NASDAQ: NTRB) 股票上涨了 19.16%，至 $5.72。该公司的市值为 5840 万美元。</li>
<li><strong>Zura Bio</strong> (NASDAQ: ZURA) 股票上涨了 16.19%，至 $5.4。其流通股的市场价值为 3.023 亿美元。</li>
<li><strong>Palisade Bio</strong> (NASDAQ: PALI) 股票上涨了 15.72%，至 $2.49。该公司的市值为 3.207 亿美元。</li>
<li><strong>Prelude Therapeutics</strong> (NASDAQ: PRLD) 股票上涨了 15.13%，至 $2.82。其流通股的市场价值为 1.54 亿美元。</li>
<li><strong>Strata Skin Sciences</strong> (NASDAQ: SSKN) 股票上涨了 14.22%，至 $1.41。其流通股的市场价值为 720 万美元。</li>
</ul>
<h3>跌幅榜</h3>
<ul>
<li><strong>Mereo BioPharma Group</strong> (NASDAQ: MREO) 股票在周一的常规交易中下跌了 90.3%，至 $0.22。其流通股的市场价值为 3.675 亿美元。</li>
<li><strong>Ultragenyx Pharmaceutical</strong> (NASDAQ: RARE) 股票下跌了 44.11%，至 $19.11。其流通股的市场价值为 32 亿美元。</li>
<li><strong>Bristol-Myers Squibb Company Celegne Contingent Value Rights</strong> (NYSE: CELGR) 股票下跌了 33.24%，至 $0.05。</li>
<li><strong>Inovio Pharmaceuticals</strong> (NASDAQ: INO) 股票下跌了 21.62%，至 $1.79。其流通股的市场价值为 1.573 亿美元。</li>
<li><strong>Trinity Biotech</strong> (NASDAQ: TRIB) 股票下跌了 17.99%，至 $0.82。其流通股的市场价值为 1910 万美元。</li>
<li><strong>Cue Biopharma</strong> (NASDAQ: CUE) 股票下跌了 15.8%，至 $0.27。其流通股的市场价值为 2960 万美元。
<strong>另见：</strong> www.benzinga.com/money/best-healthcare-stocks/</li>
</ul>
<p>本文由 Benzinga 的自动内容引擎生成，并由编辑审核。</p>

Trinity生物科技-A

Inovio 制药

MREO

百时美施贵宝

<p>在周一的盘中交易中，几只医疗保健股票经历了显著的波动。显著上涨的股票包括格林威治生命科学（Greenwich LifeSciences，GLSI），上涨 25.5% 至 25.96 美元，以及 Nutriband（NTRB），上涨 19.16% 至 5.72 美元。其他上涨的股票还有 Zura Bio（ZURA）、Palisade Bio（PALI）、Prelude Therapeutics（PRLD）和 Strata Skin Sciences（SSKN）。相反，Mereo BioPharma Group（MREO）则大幅下跌 90.3%，至 0.22 美元，而 Ultragenyx Pharmaceutical（RARE）下跌 44.11%，至 19.11 美元。其他下跌的股票包括百时美施贵宝（Bristol-Myers Squibb，CELGR）、Inovio Pharmaceuticals（INO）、Trinity Biotech（TRIB）和 Cue Biopharma（CUE）</p>

<h3>Gainers</h3>
<div class="lb-trans"><h3>涨幅榜</h3>
</div><ul>
<li><strong>Greenwich LifeSciences</strong> (NASDAQ: GLSI) stock increased by 25.5% to $25.96 during Monday's regular session. The company's market cap stands at $276.5 million.</li>
<li><strong>Nutriband</strong> (NASDAQ: NTRB) stock increased by 19.16% to $5.72. The company's market cap stands at $58.4 million.</li>
<li><strong>Zura Bio</strong> (NASDAQ: ZURA) stock rose 16.19% to $5.4. The market value of their outstanding shares is at $302.3 million.</li>
<li><strong>Palisade Bio</strong> (NASDAQ: PALI) shares moved upwards by 15.72% to $2.49. The company's market cap stands at $320.7 million.</li>
<li><strong>Prelude Therapeutics</strong> (NASDAQ: PRLD) shares increased by 15.13% to $2.82. The market value of their outstanding shares is at $154.0 million.</li>
<li><strong>Strata Skin Sciences</strong> (NASDAQ: SSKN) shares moved upwards by 14.22% to $1.41. The market value of their outstanding shares is at $7.2 million.</li>
</ul>
<div class="lb-trans"><ul>
<li><strong>Greenwich LifeSciences</strong> (NASDAQ: GLSI) 股票在周一的常规交易中上涨了 25.5%，至 $25.96。该公司的市值为 2.765 亿美元。</li>
<li><strong>Nutriband</strong> (NASDAQ: NTRB) 股票上涨了 19.16%，至 $5.72。该公司的市值为 5840 万美元。</li>
<li><strong>Zura Bio</strong> (NASDAQ: ZURA) 股票上涨了 16.19%，至 $5.4。其流通股的市场价值为 3.023 亿美元。</li>
<li><strong>Palisade Bio</strong> (NASDAQ: PALI) 股票上涨了 15.72%，至 $2.49。该公司的市值为 3.207 亿美元。</li>
<li><strong>Prelude Therapeutics</strong> (NASDAQ: PRLD) 股票上涨了 15.13%，至 $2.82。其流通股的市场价值为 1.54 亿美元。</li>
<li><strong>Strata Skin Sciences</strong> (NASDAQ: SSKN) 股票上涨了 14.22%，至 $1.41。其流通股的市场价值为 720 万美元。</li>
</ul>
</div><h3>Losers</h3>
<div class="lb-trans"><h3>跌幅榜</h3>
</div><ul>
<li><strong>Mereo BioPharma Group</strong> (NASDAQ: MREO) shares fell 90.3% to $0.22 during Monday's regular session. The market value of their outstanding shares is at $367.5 million.</li>
<li><strong>Ultragenyx Pharmaceutical</strong> (NASDAQ: RARE) shares declined by 44.11% to $19.11. The market value of their outstanding shares is at $3.2 billion.</li>
<li><strong>Bristol-Myers Squibb Company Celegne Contingent Value Rights</strong> (NYSE: CELGR) shares declined by 33.24% to $0.05.</li>
<li><strong>Inovio Pharmaceuticals</strong> (NASDAQ: INO) shares decreased by 21.62% to $1.79. The market value of their outstanding shares is at $157.3 million.</li>
<li><strong>Trinity Biotech</strong> (NASDAQ: TRIB) shares decreased by 17.99% to $0.82. The market value of their outstanding shares is at $19.1 million.</li>
<li><strong>Cue Biopharma</strong> (NASDAQ: CUE) shares declined by 15.8% to $0.27. The market value of their outstanding shares is at $29.6 million.
<strong>See Also:</strong> www.benzinga.com/money/best-healthcare-stocks/</li>
</ul>
<div class="lb-trans"><ul>
<li><strong>Mereo BioPharma Group</strong> (NASDAQ: MREO) 股票在周一的常规交易中下跌了 90.3%，至 $0.22。其流通股的市场价值为 3.675 亿美元。</li>
<li><strong>Ultragenyx Pharmaceutical</strong> (NASDAQ: RARE) 股票下跌了 44.11%，至 $19.11。其流通股的市场价值为 32 亿美元。</li>
<li><strong>Bristol-Myers Squibb Company Celegne Contingent Value Rights</strong> (NYSE: CELGR) 股票下跌了 33.24%，至 $0.05。</li>
<li><strong>Inovio Pharmaceuticals</strong> (NASDAQ: INO) 股票下跌了 21.62%，至 $1.79。其流通股的市场价值为 1.573 亿美元。</li>
<li><strong>Trinity Biotech</strong> (NASDAQ: TRIB) 股票下跌了 17.99%，至 $0.82。其流通股的市场价值为 1910 万美元。</li>
<li><strong>Cue Biopharma</strong> (NASDAQ: CUE) 股票下跌了 15.8%，至 $0.27。其流通股的市场价值为 2960 万美元。
<strong>另见：</strong> www.benzinga.com/money/best-healthcare-stocks/</li>
</ul>
</div><p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>
<div class="lb-trans"><p>本文由 Benzinga 的自动内容引擎生成，并由编辑审核。</p>
</div>

12 只医疗保健股票在周一盘中交易中出现波动